Drug Shortage Report for CATHFLO

Last updated on 2025-03-05 History

Report ID	247639
Drug Identification Number	02245859
Brand name	CATHFLO
Common or Proper name	ALTEPLASE
Company Name	HOFFMANN-LA ROCHE LIMITED
Market Status	MARKETED
Active Ingredient(s)	ALTEPLASE
Strength(s)	2MG
Dosage form(s)	POWDER FOR SOLUTION
Route of administration	INSTILLATION INSTILLATION
Packaging sizes (GTIN) Click here to see a list of all reports for this drug.	(See additional packaging sizes)
Additional packaging sizes	2MG VIAL, PACK OF 10 VIALS
ATC code	B01AD
ATC description	ANTITHROMBOTIC AGENTS
Reason for shortage	Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date	2025-02-24
Estimated end date	2025-03-14
Actual end date	2025-03-04
Shortage status	Resolved
Updated date	2025-03-05
Company comments	Normal supply distribution for Cathflo has resumed. If you have any questions regarding Cathflo supply please contact Order and Distribution Management: [email protected].
Health Canada comments
Tier 3 Status	No
Contact Address	7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 25